Bone-specific transcription factor Runx2 interacts with the 1α,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells

Molecular and Cellular Biology

Volumn 24, Issue 20, 2004, Pages 8847-8861

  Paredes, Roberto ^a   Arriagada, Gloria ^a   Cruzat, Fernando ^a   Villagra, Alejandro ^a   Olate, Juan ^a   Zaidi, Kaleem ^b   Van Wijnen, Andre ^b   Lian, Jane B ^b   Stein, Gary S ^b   Stein, Janet L ^b   Montecino, Martin ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR; GLUTATHIONE TRANSFERASE; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CHROMATIN; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; IMMUNOPRECIPITATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; BINDING SITES; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, REPORTER; MACROMOLECULAR SUBSTANCES; OSTEOBLASTS; OSTEOCALCIN; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, CALCITRIOL; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION; VITAMIN D RESPONSE ELEMENT;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 4744369224     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.20.8847-8861.2004     Document Type: Article

References (29)

1. Banerjee, C., L. R. McCabe, J. Y. Choi, S. W. Hiebert, J. L. Stein, G. S. Stein, and J. B. Lian. 1997. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J. Cell Biochem. 66:1-8.
2. Breen, E. C., A. J. van Wijnen, J. B. Lian, G. S. Stein, and J. L. Stein. 1994. In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D-dependent transcriptional upregulation in intact cells. Proc. Natl. Acad. Sci. USA 91:12902-12906.
3. Christakos, S., P. Dhawan, Y. Liu, X. Peng, and A. Porta. 2003. New insights into the mechanisms of vitamin D action. J. Cell Biochem. 88:695-705.
4. Ducy, P., R. Zhang, V. Geoffroy, A. L. Ridall, and G. Karsenty. 1997. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754.
5. Gutierrez, J., J. Sierra, R. Medina, M. Puchi, M. Imschenetzky, A. van Wijnen, J. Lian, G. Stein, J. Stein, and M. Montecino. 2000. Interaction of CBF alpha/AML/PEBP2 alpha transcription factors with nucleosomes containing promoter sequences requires flexibility in the translational positioning of the histone octamer and exposure of the CBF alpha site. Biochemistry 39:13565-13574.
6. Gutierrez, S., A. Javed, D. K. Tennant, M. van Rees, M. Montecino, G. S. Stein, J. L. Stein, and J. B. Lian. 2002. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression. J. Biol. Chem. 277:1316-1323.
7. Hsieh, J. C., P. W. Jurutka, S. Nakajima, M. A. Galligan, C. A. Haussler, Y. Shimizu, N. Shimizu, G. K. Whitfield, and M. R. Haussler. 1993. Phosphorylation of the human vitamin D receptor by protein kinase C. Biochemical and functional evaluation of the serine 51 recognition site. J. Biol. Chem. 268:15118-15126.
8. Javed, A., S. Gutierrez, M. Montecino, A. J. van Wijnen, J. L. Stein, G. S. Stein, and J, B. Lian. 1999. Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization. Mol. Cell. Biol. 19:7491-7500.
9. Kitagawa, H., R. Fujiki, K. Yoshimura, Y. Mezaki, Y. Uematsu, D. Matsui, S. Ogawa, K. Unno, M. Okubo, A. Tokita, T. Nakagawa, T. Ito, Y. Ishimi, H. Nagasawa, T. Matsumoto, J. Yanagisawa, and S. Kato. 2003. The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113:905-917.
10. Komori, T., H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R. T. Bronson, Y. H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
11. Lian, J. B., J. L. Stein, G. S. Stein, M. Montecino, A. J. van Wijnen, A. Javed, and S. Gutierrez. 2001. Contributions of nuclear architecture and chromatin to vitamin D-dependent transcriptional control of the rat osteocalcin gene. Steroids 66:159-170.
12. Majeska, R. J., S. B. Rodan, and G. A. Rodan. 1980. Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology. 107:1494-1503.
13. Metivier, R., G. Penot, M. Hubner, G. Reid, H. Brand, M. Kos, and F. Gannon. 2003. Estrogen receptor-α direct ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763.
14. Montecino, M., J. Lian, G. Stein, and J. Stein. 1996. Changes in chromatin structure support constitutive and developmentally regulated transcription of the bone-specific osteocalcin gene in osteoblastic cells. Biochemistry 35:5093-5102.
15. Montecino, M., B. Frenkel, A. J. van Wijnen, J. B. Lian, G. S. Stein, and J. L. Stein. 1999. Chromatin hyperacetylation abrogates vitamin D-mediated transcriptional upregulation of the tissue-specific osteocalcin gene in vivo. Biochemistry. 26:1338-1345.
16. Otto, F., A. P. Thornell, T. Crompton, A. Denzel, K. C. Gilmour, I. R. Rosewell, G. W. H. Stamp, R. S. P. Beddington, S. Mundlos, B. R. Olsen, P. B. Selby, and M. J. Owen. 1997. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
17. Owen, T. A., M. Aronow, V. Shalhoub, L. M. Barone, L. Wilming, M. S. Tassinari, M. B. Kennedy, S. Pockwinse, J. B. Lian, and G. S. Stein. 1990. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J. Cell Physiol. 143:420-430.
18. 3 receptor at the distal promoter region of the bone-specific osteocalcin gene requires nucleosomal remodelling. Biochem. J. 363:667-676.
19. Rachez, C., and L. P. Freedman. 2000. Mechanisms of gene regulation by vitamin D(3) receptor: a network of coactivator interactions. Gene 246:9-21.
20. Rachez, C., M. Gamble, C. P. B. Chang, G. B. Atkins, M. A. Lazar, and L. P. Freedman. 2000. The DRIP complex and SRC-1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes. Mol. Cell. Biol. 20:2718-2726.
21. Rachez, C., B. D. Lemon, Z. Suldan, V. Bromleigh, M. Gamble, A. M. Naar, H. Erdjument-Bromage, P. Tempst, and L. P. Freedman. 1999. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398:824-828.
22. Rachez, C., Z. Suldan, J. Ward, C. P. Chang, D. Burakov, H. Erdjument-Bromage, P. Tempst, and L. P. Freedman. 1998. A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev. 12:1787-1800.
23. Shen, J., M. Montecino, L. B. Lian, G. S. Stein, A. J. Van Wijnen, and J. L. Stein. 2002. Histone acetylation in vivo at the osteocalcin locus is functionally linked to vitamin D-dependent, bone tissue-specific transcription. J. Biol. Chem. 277:20284-20292.
24. 3 receptor but not p300 intrinsic histone acetyltransferase activity. Mol. Cell. Biol. 23:3339-3351.
25. Soutoglou, E., and I. Talianidis. 2002. Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation. Science 295:1901-1904.
26. Staal, A., A. J. vanWijnen, J. C. Birkenhager, H. A. P. Pols, J. Prahl, H. DeLuca, M. P. Gaub, J. B. Lian, G. S. Stein, J. P. T. M. vanLeeuwen, and J. L. Stein. 1996. Distinct conformations of vitamin D receptor retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol. Endocrinol. 10:1444-1456.
27. Thompson, P. D., P. W. Jurutka, C. A. Haussler, G. K. Whitfield, and M. R. Haussler. 1998. Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions. J. Biol. Chem. 273:8483-8491.
28. Zeng, C., A. J. van Wijnen, J. L. Stein, S. Meyers, W. Sun, L. Shopland, J. B. Lawrence, S. Penman, J. B. Lian, G. S. Stein, and S. W. Hiebert. 1997. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc. Natl. Acad. Sci. USA 94:6746-6751.
29. Zhang, Y. W., N. Yasui, K. Ito, G. Huang, M. Fujii, J. Hanai, H. Nogami, T. Ochi, K. Miyazono, and Y. Ito. 2000. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. USA 97:10549-10554.